Literature DB >> 7656121

New approaches and technologies in drug design and discovery.

M L Kleinberg1, L A Wanke.   

Abstract

Traditional and novel approaches to drug design and screening techniques and strategies are described, and the potential benefits of new technologies are discussed. Sophisticated new approaches and technologies in the discovery and design of new drugs are replacing the traditional methods. Rational or structure-based methods of drug design and discovery that integrate techniques of x-ray crystallography, computational chemistry, and nuclear magnetic resonance spectroscopy are becoming the predominant methods. New technologies and methods for drug screening may yield significant savings in time and money, as well as increased diversity and specificity of lead compounds. Intense research activity is now being focused on small-molecule structure-based drug design, in which drugs would mimic the complex molecular interactions of natural proteins. The new approaches and technologies hold promise for dramatic therapeutic advances, particularly in the areas of transcriptionally active drugs and gene therapy. Rapid advances in drug design and screening, brought about through new technologies, may yield significant therapeutic advances and cost-effective therapies.

Mesh:

Substances:

Year:  1995        PMID: 7656121     DOI: 10.1093/ajhp/52.12.1323

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


  2 in total

1.  Data supplementation: a pharmacokinetic/pharmacodynamic knowledge creation approach for characterizing an unexplored region of the response surface.

Authors:  Ene I Ette; Hui-May Chu; Christopher J Godfrey
Journal:  Pharm Res       Date:  2005-04-07       Impact factor: 4.200

2.  Prediction of quinolone activity against Mycobacterium avium by molecular topology and virtual computational screening.

Authors:  R Gozalbes; M Brun-Pascaud; R García-Domenech; J Gálvez; P M Girard; J P Doucet; F Derouin
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.